Decreased serum levels of adiponectin in subjects with autism

The neurobiological basis for autism remains poorly understood. We hypothesized that adipokines, such as adiponectin, may play a role in the pathophysiology of autism. In this study, we examined whether serum levels of adiponectin are altered in subjects with autism. We measured serum levels of adip...

Full description

Saved in:
Bibliographic Details
Published inProgress in neuro-psychopharmacology & biological psychiatry Vol. 34; no. 3; pp. 455 - 458
Main Authors Fujita-Shimizu, Azusa, Suzuki, Katsuaki, Nakamura, Kazuhiko, Miyachi, Taishi, Matsuzaki, Hideo, Kajizuka, Masanobu, Shinmura, Chie, Iwata, Yasuhide, Suda, Shiro, Tsuchiya, Kenji J., Matsumoto, Kaori, Sugihara, Genichi, Iwata, Keiko, Yamamoto, Shigeyuki, Tsujii, Masatsugu, Sugiyama, Toshiro, Takei, Nori, Mori, Norio
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 16.04.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The neurobiological basis for autism remains poorly understood. We hypothesized that adipokines, such as adiponectin, may play a role in the pathophysiology of autism. In this study, we examined whether serum levels of adiponectin are altered in subjects with autism. We measured serum levels of adiponectin in male subjects with autism ( n = 31) and age-matched healthy male subjects ( n = 31). The serum levels of adiponectin in the subjects with autism were significantly lower than that of normal control subjects. The serum adiponectin levels in the subjects with autism were negatively correlated with their domain A scores in the Autism Diagnostic Interview—Revised, which reflects their impairments in social interaction. This study suggests that decreased levels of serum adiponectin might be implicated in the pathophysiology of autism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0278-5846
1878-4216
1878-4216
DOI:10.1016/j.pnpbp.2009.12.020